Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
- Resource Type
- Source
- Nature Communications, Vol 12, Iss 1, Pp 1-1 (2021)
- Subject
Multidisciplinary business.industry Science Endocrine therapy General Physics and Astronomy Translational research General Chemistry medicine.disease General Biochemistry, Genetics and Molecular Biology Breast cancer Cancer research Medicine business Protein kinase B - Language
- English
- ISSN
- 2041-1723